Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
09/2010
09/28/2010CA2415475C Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
09/10/2010WO2010100623A1 Process for the preparation of quetiapine fumarate
09/07/2010CA2485349C A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor
08/2010
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/18/2010EP1781646B1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-1-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE
08/12/2010US20100203135 Skin Equivalent Culture
08/05/2010WO2010085976A1 Process for the synthesis of quetiapine
07/2010
07/21/2010CN101781271A Simple industrial technology for preparing diltiazem from chiral intermediates
07/20/2010CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
06/2010
06/24/2010WO2010070667A2 Novel process for the preparation of 7-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2) thiazepin-11-yl)amino)heptanoate
06/24/2010US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
06/24/2010US20100160290 Pharmaceutical composition for treating alzheimer's disease
06/17/2010US20100152440 NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)
06/16/2010CN1872846B Method of preparing 2-benzothiazepines derivative
06/16/2010CN101735211A Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor
06/10/2010US20100144715 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers
06/03/2010WO2010062565A1 Muscarinic agonists
06/03/2010WO2010042392A3 Hiv integrase inhibitors
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
05/2010
05/27/2010US20100130474 Alpha7 nicotinic acetylcholine receptor inhibitors
05/12/2010EP1856073B1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE
05/12/2010CN101704799A Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/06/2010WO2010051239A1 Tianeptine sulfate salt forms and methods of making and using the same
05/06/2010US20100112051 Tianeptine sulfate salt forms and methods of making and using the same
04/2010
04/27/2010US7704990 4-(Piperidinomethylaminosulfonyl),7-(methoxy-)-1,4-benzothiazepineprepared by the reaction of 7-(methoxy-)-1,4-benzothiazepine andpiperidinomethylaminosulfonyl chloride using a basic catalyst; ranodinereceptors that regulate calcium channel functioning in cells; skeletal muscular, cardiac disorders
04/21/2010EP2177224A2 Agents for preventing and treating disorders involving modulation of the RyR receptors
04/15/2010WO2010042392A2 Hiv integrase inhibitors
04/15/2010WO2010042391A2 Hiv integrase inhibitors
04/15/2010CA2738814A1 Hiv integrase inhibitors
04/08/2010US20100087419 Hiv integrase inhibitors
03/2010
03/30/2010US7687622 Process for preparing quetiapine fumarate
03/25/2010WO2010033270A1 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/24/2010CN101676275A preparation method of quetiapine fumarate
03/18/2010US20100069356 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/16/2010US7678902 Reacting 2,2'-dithiosalicylic acid with 1-chloro-2-nitrobenzene in basic aqueous solution, conducting nitro group reduction reaction, simultaneously cyclizing and chlorinating in solvent, and halogenating; environmentally friendly, cost efficiency
03/04/2010US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
03/02/2010US7671195 Process for preparing dibenzothiazepine compounds
02/2010
02/25/2010WO2010021149A1 Spiro compound capable of inhibiting acid secretion
02/18/2010US20100041638 Chemical Compounds 293
02/10/2010EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease
02/09/2010CA2557576C Novel benzothiazepine and benzothiepine compounds
02/04/2010US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
01/2010
01/28/2010US20100022513 Organic compounds
01/28/2010US20100022509 Inhibitors of MshC and Homologs Thereof, and Methods of Identifying Same
01/28/2010US20100022500 Macrocyclic Lactams and Pharmaceutical Use Thereof
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
01/21/2010US20100016579 Crystalline forms of quetiapine hemifumarate
01/20/2010EP2144892A2 Improved process for preparing quetiapine fumarate
01/13/2010EP2035400B1 Method for the preparation of salts of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol (quetiapine)
01/06/2010EP1427713B1 Benzothiazepine derivatives for the treatment of hyperlipidemia
01/06/2010CN101619047A Preparation process of quetiadine hemifumarate
01/06/2010CN100577653C Process for producing dibenzo thionitrogen tropilidine derivative
12/2009
12/30/2009EP2137157A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same
12/23/2009WO2009154563A1 Dibenzothiazepine derivatives and use thereof
12/23/2009EP1664007B1 Preparation of quetiapine
12/23/2009CA2728675A1 Dibenzothiazepine derivatives and use thereof
12/17/2009WO2009151392A1 Novel derivatives of 11-piperazin-l-yldibenzo [b,f] [1,4] thiazepine for treating at least one syndrome or condition associated with schizophrenia and other psychotic disorders
12/16/2009CN100569761C Method for preparing pharmaceutical pure quetiapine fumarate
12/02/2009EP2124908A1 Compounds and uses thereof
12/01/2009US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
11/2009
11/25/2009EP2120957A1 Compounds and uses thereof
11/25/2009EP2120563A1 Compounds and uses thereof
11/12/2009US20090281077 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
11/10/2009US7615536 Hyperlipidemia, arteriosclerosis and hypercholesterolemia treatment
11/05/2009WO2009004480A3 Quetiapine salts and their polymorphs
11/03/2009US7612055 Macrocyclic lactams and pharmaceutical use thereof
10/2009
10/27/2009CA2415050C Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepines
10/20/2009CA2379294C Process for preparing dibenzothiazepine derivatives
10/13/2009US7601695 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal
10/07/2009EP1000043B1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
09/2009
09/30/2009EP1243584B1 Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide
09/16/2009EP2099459A1 Compounds and uses thereof
09/11/2009WO2009111463A1 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
09/11/2009CA2717523A1 Process for preparing benzothiazepines from .gamma.-aminoalkylbenzenes
09/10/2009US20090227788 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
08/2009
08/20/2009US20090209593 Novel antibacterial agents
08/19/2009CN101511804A Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
08/18/2009US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS
08/06/2009WO2009095529A1 A process for the preparation of quetiapine
08/06/2009CA2711395A1 A process for the preparation of quetiapine
08/05/2009EP1742707A4 Treatment of cns disorders using cns target modulators
08/05/2009EP1430040B1 Benzothiazepine derivatives
08/05/2009CN101500576A Agents for preventing and treating disorders involving modulation of the RYR receptors
07/2009
07/28/2009US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity
07/22/2009EP1567524B1 Thia-epothilone derivatives for the treatment of cancer
07/22/2009CN100516022C Process for production of high-purity enamines
07/21/2009US7563785 Quetiapine analogs and methods of use thereof
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176800 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
07/09/2009DE10297841B3 Preparation of diltiazem useful to treat angina involves synthesizing (2R,3S)-(-)-ethyl-2,3-dihydroxy-3-(4-methoxyphenyl)propionate using multifunctional catalyst, ring opening of the cyclic sulfite by 2-aminothiophenol and cyclization
06/2009
06/18/2009WO2009075691A1 Cb-1 modulating compounds and their use
06/17/2009EP2069319A1 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
06/11/2009US20090149442 Atypical antipsychotic agents having low affinity for the D2 receptor
06/09/2009US7544678 Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
06/03/2009CN100494185C Novel quaternary ammonium compounds
05/2009
05/27/2009EP0934287B1 Heterocyclic esters and amides
05/27/2009CN100491333C Process for production of high-purity enamines
05/19/2009CA2338651C Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 20